Trefoil Therapeutics
PrivateLast Round
Series A
Extension
Mar 8, 2022
Total Funding Raised
$45.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Trefoil Therapeutics is a biotechnology company that develops regenerative pharmacologic treatments for corneal diseases using engineered fibroblast growth factor-1 protein technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trefoil Therapeutics Comparables
Compare Trefoil Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emmecell | 85% | |
| ActualEyes, Inc. | 79% | |
| Alcon | 77% | |
Trefoil Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jul 16, 2019 | ||||
| Series 1 | Jan 5, 2017 | ||||
| Grant | Oct 20, 2015 |
Trefoil Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hatteras Venture Partners | Series A, Series 1 |
| Correlation Ventures | Series 1, Series A |
| InFocus Capital Partners | Series 1, Series A |
| National Eye Institute | Grant |
| Access Biotechnology | Series A |
| AJU IB Investment | Series 1, Series A |
| Solasta Ventures | Series 1, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 78% MoM.
- Jan 5, 2017
$5.2M round led by Hatteras Venture Partners.
Trefoil Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trefoil Therapeutics's valuation, stock price, and market status.